Agomab Therapeutics AGMB
NASDAQ AGMB
$11.37 -0.33 (-2.82%)
As of: Sep 22, 2026 · 10:46 AM EDT

Agomab Therapeutics NV (AGMB) Debt Ratio (2025 - 2026)

Agomab Therapeutics (AGMB) posted Debt Ratio of 0.02 for Q2 2026, down 45.46% on a QoQ basis from 0.04 in Q4 2025.

Analysis

Agomab Therapeutics NV (AGMB) Debt Ratio (2025 - 2026) Analysis & Trends

Agomab Therapeutics has reported Debt Ratio for 2 years, with the latest figure at 0.02 in Q2 2026.

  • On a quarterly basis, Debt Ratio changed N/A year-over-year to 0.02 in Q2 2026; TTM through Jun 2026 was 0.02, a N/A change from a year earlier, with the FY2025 full-year figure at 0.04, changed N/A from the prior year.
  • Debt Ratio was 0.02 for Q2 2026 at Agomab Therapeutics, down from 0.04 in the prior quarter.
  • The five-year high for Debt Ratio was 0.04 in Q4 2025, with the low at 0.02 in Q2 2026.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.02
Dec 31, 2025 0.04
API Access

Agomab Therapeutics NV Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=AGMB&period=max&api_key=YOUR_API_KEY